In vivo treatment of influenza virus infection with a MEK inhibitor

MEK 抑制剂体内治疗流感病毒感染

• 批准号: 183182
• 负责人: Hirasawa Kensuke
• 金额: $ 7.15万
• 依托单位: Memorial University of Newfoundland
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2009
• 资助国家: 加拿大
• 起止时间: 2009-04-01 至 2010-04-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=183182&lang=en
• 关键词: Infection; Influenza Virus; Innate Immunity; Ras/Mek/Erk Pathway

Virus infection is recognized as a current growing problem which causes damages in public health and societies. Despite very successful vaccinations against some viruses in the past, there are not many anti-viral drugs available for ongoing infection. Bas

病毒感染是目前公认的日益严重的问题，它对公共卫生和社会造成损害。尽管过去针对一些病毒的疫苗接种非常成功，但没有多少抗病毒药物可用于持续感染。Bas